Our experts are focused on developing innovative compounds for Alzheimer's, Parkinson's.

 Our scientists are currently working on novel and innovative treatments to address the unmet needs of people living with diabetes, obesity, cardiovascular disease, Diabetic Complications and MASH.

 As science evolves beyond broad immunosuppression and into more selective agents, patients living with autoimmune and inflammatory disease have new hope.